Biologic Videos
-
Webinar Teaser: LBA Vs. LC-MS
2/6/2025
Why are so many sponsors shifting from Ligand-Binding Assays (LBA) to Liquid Chromatography-Mass Spectrometry (LC-MS) for large molecule protein analysis?
-
LBA Vs. LC-MS: Competing Technologies At A Development Crossroad
2/6/2025
Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.
-
Lonza Capacity Update January 2025: Fill/Finish
1/31/2025
Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.
-
Jubilant HollisterStier Capacity Update January 2025: Fill/Finish
1/31/2025
From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.
-
FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish
1/31/2025
Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.
-
Alcami Capacity Update January 2025: Fill/Finish
1/31/2025
Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.
-
Capacity Update January 2025: Fill/Finish
1/31/2025
This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.
-
Northway Biotech Capacity Update January 2025: Large Molecule Development
1/28/2025
Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.
-
Mabion Capacity Update January 2025: Large Molecule Development
1/28/2025
Go on a virtual tour of our GMP-certified facility, where we uphold our expanded capabilities for large molecule development to the highest standards for clinical and commercial manufacturing.
-
KBI Biopharma Capacity Update January 2025: Large Molecule Development
1/28/2025
Follow along as Derek Ryan, Sr. Director of Analytical Development, showcases our high-throughput technology and digital tools for process understanding and optimizing decision-making.